These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20939684)

  • 21. Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization.
    Take K; Mochida T; Maki T; Satomi Y; Hirayama M; Nakakariya M; Amano N; Adachi R; Sato K; Kitazaki T; Takekawa S
    PLoS One; 2016; 11(3):e0150976. PubMed ID: 26938273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus.
    Ojo OO; Abdel-Wahab YH; Flatt PR; Mechkarska M; Conlon JM
    Diabetes Obes Metab; 2011 Dec; 13(12):1114-22. PubMed ID: 21736689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
    Chen HC; Farese RV
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and optimization of adamantane carboxylic acid derivatives as potent diacylglycerol acyltransferase 1 inhibitors for the potential treatment of obesity and diabetes.
    Pagire SH; Pagire HS; Lee GB; Han SJ; Kwak HJ; Kim JY; Kim KY; Rhee SD; Ryu JI; Song JS; Bae MA; Park MJ; Kim D; Lee DH; Ahn JH
    Eur J Med Chem; 2015 Aug; 101():716-35. PubMed ID: 26218650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and design of a novel series of MGAT2 inhibitors.
    Barlind JG; Buckett LK; Crosby SG; Davidsson Ö; Emtenäs H; Ertan A; Jurva U; Lemurell M; Gutierrez PM; Nilsson K; O'Mahony G; Petersson AU; Redzic A; Wågberg F; Yuan ZQ
    Bioorg Med Chem Lett; 2013 May; 23(9):2721-6. PubMed ID: 23541669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipogenic enzymes as therapeutic targets for obesity and diabetes.
    Lenhard JM
    Curr Pharm Des; 2011; 17(4):325-31. PubMed ID: 21375498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological evaluation of conformationally constrained glycerol 3-phosphate acyltransferase inhibitors.
    Wydysh EA; Vadlamudi A; Medghalchi SM; Townsend CA
    Bioorg Med Chem; 2010 Sep; 18(17):6470-9. PubMed ID: 20692840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical Assays for Ghrelin Acylation and Inhibition of Ghrelin O-Acyltransferase.
    Sieburg MA; Cleverdon ER; Hougland JL
    Methods Mol Biol; 2019; 2009():227-241. PubMed ID: 31152408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus.
    Li X; Wang J; Yang Q; Shao S
    Am J Med Sci; 2017 Oct; 354(4):408-414. PubMed ID: 29078846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional group and stereochemical requirements for substrate binding by ghrelin O-acyltransferase revealed by unnatural amino acid incorporation.
    Cleverdon ER; Davis TR; Hougland JL
    Bioorg Chem; 2018 Sep; 79():98-106. PubMed ID: 29738973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
    Goldstein BJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of glycerol-3-phosphate acyltransferase as a potential treatment for insulin resistance and type 2 diabetes.
    Thuresson ER
    Curr Opin Investig Drugs; 2004 Apr; 5(4):411-8. PubMed ID: 15134282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
    Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
    J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
    Irwin N; Pathak V; Flatt PR
    Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
    Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.
    Mochida T; Take K; Maki T; Nakakariya M; Adachi R; Sato K; Kitazaki T; Takekawa S
    FEBS Open Bio; 2020 Mar; 10(3):316-326. PubMed ID: 31837122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of central ghrelin O-acyltransferase by vivo-morpholino reduces body mass of rats fed a high-fat diet.
    Wellman M; Abizaid A
    Peptides; 2015 Aug; 70():17-22. PubMed ID: 26028164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.